ClinicalTrials.Veeva

Menu

Muscle Training Effectiveness in the Degree of Dyspnea and Aerobic Capacity in COPD

C

CES University

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Dyspnea
Chronic Obstructive Pulmonary Disease

Treatments

Other: Yoga
Other: Physiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT01452932
UCESCOPD

Details and patient eligibility

About

Objective: To estimate the effectiveness of muscle training, the degree of dyspnea and aerobic capacity in patients over 50 with COPD, in a health care institution provider in Antioquia.

Question: What is the effectiveness of muscle training, in the degree of dyspnea and aerobic capacity in COPD patients over 50 years, in a health service institution provider in the department of Antioquia?

Hypothesis: Muscle training causes changes in the degree of dyspnea and aerobic capacity, other than the breathing exercises and relaxation

Design: Randomized clinical trial with allocation and blinding of the autcomes assesor.

Participants: COPD patients stage II and II, male and female, over 50 years old, who are attending to a community health service provider in the department of Antioquia.

Intervention: A physiotherapeutic intervention using PNF technique was applied to the experimental physiotherapy group versus Yoga sessions applied to the other group. Twelve weeks protocol performing three sessions per week.

Outcome measures: Dyspnea degree and aerobic capacity was measured using the MMRC scale and the six minute walking test respectively at the begining and the end of the study.

Full description

Chronic obstructive pulmonary disease (COPD) is defined by GOLD (The Global Initiative for Chronic Obstructive Lung Disease) as a disease process characterized by progressive airflow limitation associated with an abnormal inflammatory response of the lungs to particles or harmful gases and is not fully reversible. This restriction generates an expiratory flow of air entrapment resulting hyperinflation, coupled with the effects that systemic, structural changes occur in skeletal muscles which leads to greater fatigue causing dyspnea. Consequently, patients with COPD require participation of accessory muscles of respiration, which should have a dual function during activities involving the upper limbs, to supply the ventilatory requirements and movements of the shoulder girdle, which increases dyspnea carrying the patient to stop their activities, leading to physical deconditioning and progressively decreasing aerobic capacity. This demonstrates the need to improve the resistance of the upper limb muscles in these patients, thus contributing to a reduction in the degree of dyspnea and improved their aerobic capacity. The investigators propose a study aimed at determining the effectiveness of muscle training in the degree of dyspnea and aerobic capacity in COPD.

Enrollment

44 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women over 50 years with a diagnosis of COPD stage II and III according to GOLD classification, performed spirometry
  • Patients who manifest dyspnea on MRC
  • Patients SGSS affiliates.
  • COPD controlled, verified medical history
  • Voluntary participation in informed consent

Exclusion criteria

  • Higher mental functions altered
  • Degenerative musculoskeletal diseases (acute state)
  • Multisystem disease not controlled
  • Perform a current fitness program

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

44 participants in 2 patient groups

Physiotherapy
Experimental group
Description:
Group of participants who recive physiotherapy treatment using Kabat technique for the upper limbs resistance training during 12 weeks
Treatment:
Other: Physiotherapy
Yoga
Other group
Description:
Group of participants who recive Yoga sessions during 12 weeks
Treatment:
Other: Yoga

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems